Year-end Sale % OFF 
Abstract
The application of cold physical plasma in head and neck cancer patients is moving upwards in the pyramid of evidence‐based medicine (EBM). The effectiveness of plasma in cancer cell lines, cultivated human tumour cells, human tumour specimen freshly explanted from patients, animal model tumours, and animals with transplanted human tumour stem cells is well documented. There is consent among experts, referred to as EBM‐level IV, about the response to plasma in experimental settings and proof of concept by clinical pilot studies, EBM‐level III, for plasma treatment of head and neck cancer. If there is a manageable amount of tumour stem cells, like in precancerous lesions of oral mucosa or in small tumours like early basal cell carcinoma of the skin, plasma could become a clinical treatment option soon. Currently, it is already a concept in palliative care of patients with locally advanced head and neck cancer and contaminated ulcerations because of proven effectiveness against microbial pathogens. Patients greatly appreciate that plasma reduces strong fetid odour and pain while not being accompanied by serious side effects.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
